^
Association details:
Biomarker:TLR3 overexpression
Cancer:Clear Cell Renal Cell Carcinoma
Drug Class:Immunotherapy
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
Source:
Title:

168 Associations of high toll-like receptor 3 gene expression and favorable anti-tumor immune microenvironment in metastatic clear cell renal cell carcinoma treated with immune checkpoint inhibitors

Published date:
11/04/2023
Excerpt:
Among the 25 patients who met the inclusion criteria, the major response rate was 50% for 6 patients with high TLR3 gene expression (>75th percentile)...High intratumoral TLR3 gene expression was associated with a higher rate of major responses in ccRCC patients treated with immune checkpoint inhibitors (ICIs).
DOI:
10.1136/jitc-2023-SITC2023.0168